These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 7625148)

  • 1. Olfactory function in atypical parkinsonian syndromes.
    Wenning GK; Shephard B; Hawkes C; Petruckevitch A; Lees A; Quinn N
    Acta Neurol Scand; 1995 Apr; 91(4):247-50. PubMed ID: 7625148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
    Ozsancak C; Auzou P; Dujardin K; Quinn N; Destée A
    J Neurol; 2004 Nov; 251(11):1317-23. PubMed ID: 15592726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Corticobasal degeneration. The significance of clinical criteria for establishing the diagnosis].
    Feifel E; Brenner M; Teiwes R; Lücking CH; Deuschl G
    Nervenarzt; 1994 Oct; 65(10):653-9. PubMed ID: 7808563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corticobasal degeneration and progressive supranuclear palsy--differentiation by somatosensory-evoked potentials].
    Miwa H; Mori H; Abe K; Hoshino I; Mizuno Y
    No To Shinkei; 1996 Mar; 48(3):253-7. PubMed ID: 8868336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
    Mueller A; Reuner U; Landis B; Kitzler H; Reichmann H; Hummel T
    Mov Disord; 2006 Sep; 21(9):1311-6. PubMed ID: 16763975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders?
    McKinnon JH; Demaerschalk BM; Caviness JN; Wellik KE; Adler CH; Wingerchuk DM
    Neurologist; 2007 Nov; 13(6):382-5. PubMed ID: 18090718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory function in Parkinsonian syndromes.
    Müller A; Müngersdorf M; Reichmann H; Strehle G; Hummel T
    J Clin Neurosci; 2002 Sep; 9(5):521-4. PubMed ID: 12383407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.
    Suzuki M; Hashimoto M; Yoshioka M; Murakami M; Kawasaki K; Urashima M
    BMC Neurol; 2011 Dec; 11():157. PubMed ID: 22192419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfaction and Parkinson's syndromes: its role in differential diagnosis.
    Katzenschlager R; Lees AJ
    Curr Opin Neurol; 2004 Aug; 17(4):417-23. PubMed ID: 15247536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients.
    Müller A; Reichmann H; Livermore A; Hummel T
    J Neural Transm (Vienna); 2002 May; 109(5-6):805-11. PubMed ID: 12111470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy.
    Greene P
    Continuum (Minneap Minn); 2019 Aug; 25(4):919-935. PubMed ID: 31356287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical Parkinson syndrome].
    Wenning GK; Pramstaller PP; Ransmayr G; Poewe W
    Nervenarzt; 1997 Feb; 68(2):102-15. PubMed ID: 9173309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysis.
    Yu F; Barron DS; Tantiwongkosi B; Fox P
    Brain Behav; 2015 Jun; 5(6):e00329. PubMed ID: 26085961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders.
    Kobari M; Fukuuchi Y; Shinohara T; Obara K; Nogawa S
    J Neurol Sci; 1995 Feb; 128(2):212-8. PubMed ID: 7738597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory function combined with morphology distinguishes Parkinson's disease.
    Sengoku R; Matsushima S; Bono K; Sakuta K; Yamazaki M; Miyagawa S; Komatsu T; Mitsumura H; Kono Y; Kamiyama T; Ito K; Mochio S; Iguchi Y
    Parkinsonism Relat Disord; 2015 Jul; 21(7):771-7. PubMed ID: 25986741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.
    Watanabe Y; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Uchiyama T; Kadowaki T; Matsubara T; Hirata K
    Intern Med; 2017 Nov; 56(21):2871-2878. PubMed ID: 28943542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential diagnosis of Parkinson's disease.
    Poewe W; Wenning G
    Eur J Neurol; 2002 Nov; 9 Suppl 3():23-30. PubMed ID: 12464118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes.
    Wolters A; Classen J; Kunesch E; Grossmann A; Benecke R
    Mov Disord; 2004 May; 19(5):518-28. PubMed ID: 15133815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.